Elanco Animal Health Incorporated Common Stock vs. Eli Lilly & Co.
ELAN
Elanco Animal Health Incorporated Common Stock
$23.15 -0.09%
VS LLYEli Lilly & Co.
$1164.89 +1.04%
Eli Lilly & Co. (LLY) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ELAN | LLY | |
|---|---|---|
| Market Cap | $11.58 billion | $1.03 trillion |
| Revenue (TTM) | $5.02 billion | $79.67 billion |
| Net Income (TTM) | $-199,000,000 | $26.71 billion |
LLY leads on 3 of 3 size & scale factors.
Valuation
| ELAN | LLY | |
|---|---|---|
| P/E Ratio | — | 39.10 |
| Price / Book | 1.76 | 30.33 |
| Price / Sales | 2.31 | 12.90 |
ELAN leads on 2 of 2 valuation factors.
Profitability
| ELAN | LLY | |
|---|---|---|
| Net Margin | -3.96% | 33.53% |
| Return on Equity | -3.02% | 78.84% |
LLY leads on 2 of 2 profitability factors.
Dividend
| ELAN | LLY | |
|---|---|---|
| Dividend Yield | — | 0.59% |
| Payout Ratio | — | 23.23 |
ELAN and LLY split the dividend factors evenly.
Risk & Sentiment
| ELAN | LLY | |
|---|---|---|
| Short Interest | 0.50% | 1.29% |
ELAN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ELAN overview, ELAN financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.